Pre-treatment plasma concentrations of soluble MHC class I polypeptide-related sequence A (sMICA) and transforming growth factor (TGF)-β1 in head and neck squamous cell carcinoma (HNSCC) patients.
- Jenny Ling-Yu Chen (5621012)
- Chien-Chung Chang (5621015)
- Yu-Sen Huang (5621018)
- Hung-Yang Kuo (5621021)
- Tzu-Yu Chen (2889935)
- Chun-Wei Wang (727240)
- Sung-Hsin Kuo (563155)
- Yu-Li Lin (258478)
Publication date
August 2018
DOI Publisher
Public Library of Science (PLoS)Abstract
Mean and standard deviation of pre-treatment levels of plasma (a,b,c) sMICA and (d, e, f) TGF-β1 in HNSCC patients according to stage, site, or p16 overexpression. P-values for statistical comparisons of pre-treatment sMICA or TGF-β1 levels between groups were calculated using the nonparametric Mann-Whitney U test. (TIF)</p
Add to ORKG